Overview of Dr. Abramson
Dr. David Abramson is an ophthalmologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. Dr. Abramson received Dr. Abramsons medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 48 years. Dr. Abramson is experienced in retinoblastoma, orbital tumors, and intraocular melanoma. He is the first Chief of Ophthalmic Oncology at MSKCC where he is a tenured professor in Surgery, Pediatrics and Radiation oncology. He has published more than 800 articles which have been cited more than 20,000 times.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- Albert Einstein College of MedicineClass of 1969
Certifications & Licensure
- NY State Medical License 1970 - 2026
- CO State Medical License 2000 - 2025
- MA State Medical License 1973 - 2019
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Lifetime Achievement Award American Academy of Ophthalmology, 2015
- Stallard Medal Cambridge University, 2015
- Heed Alumni Award Heed Foundation, 2012
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsImpact of Hurricanes and Associated Extreme Weather Events on Cardiovascular Health: A Scoping Review.Arnab K Ghosh, Michelle R Demetres, Benjamin P Geisler, Shakirah N Ssebyala, Tianyi Yang
Environmental Health Perspectives. 2022-11-01 - 119 citationsRetinoblastoma.Helen Dimaras, Timothy W Corson, David Cobrinik, Abby White, Junyang Zhao
Nature Reviews. Disease Primers. 2015-08-27 - 6 citationsDetectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma.Jasmine H Francis, Christopher A Barker, A Rose Brannon, Julia Canestraro, Melissa Robbins
Investigative Ophthalmology & Visual Science. 2022-12-01
Journal Articles
- Growth Patterns of Survivors of Retinoblastoma Treated with Ophthalmic Artery ChemosurgeryJasmine H Francis, Y Pierre Gobin, David H Abramson, PLoS One
- Total Retinal Detachments Due to Retinoblastoma: Outcomes Following Intra-Arterial chemotherapy/ophthalmic Artery ChemosurgeryIra J Dunkel, Jasmine H Francis, Y Pierre Gobin, Scott E Brodie, David H Abramson, PLoS One
Press Mentions
- Hearing Evaluations in Children with Retinoblastoma Treated with Intra-Arterial Carboplatin Chemotherapy: A Single Institution ReviewSeptember 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: